DEAD Box 1 Facilitates Removal of RNA and Homologous Recombination at DNA Double-Strand Breaks

Mol Cell Biol. 2016 Oct 28;36(22):2794-2810. doi: 10.1128/MCB.00415-16. Print 2016 Nov 15.

Abstract

Although RNA and RNA-binding proteins have been linked to double-strand breaks (DSBs), little is known regarding their roles in the cellular response to DSBs and, if any, in the repair process. Here, we provide direct evidence for the presence of RNA-DNA hybrids at DSBs and suggest that binding of RNA to DNA at DSBs may impact repair efficiency. Our data indicate that the RNA-unwinding protein DEAD box 1 (DDX1) is required for efficient DSB repair and cell survival after ionizing radiation (IR), with depletion of DDX1 resulting in reduced DSB repair by homologous recombination (HR). While DDX1 is not essential for end resection, a key step in homology-directed DSB repair, DDX1 is required for maintenance of the single-stranded DNA once generated by end resection. We show that transcription deregulation has a significant effect on DSB repair by HR in DDX1-depleted cells and that RNA-DNA duplexes are elevated at DSBs in DDX1-depleted cells. Based on our combined data, we propose a role for DDX1 in resolving RNA-DNA structures that accumulate at DSBs located at sites of active transcription. Our findings point to a previously uncharacterized requirement for clearing RNA at DSBs for efficient repair by HR.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Cell Survival / radiation effects
  • DEAD-box RNA Helicases / genetics
  • DEAD-box RNA Helicases / metabolism*
  • DNA Breaks, Double-Stranded
  • DNA Repair*
  • Gene Expression Regulation
  • HeLa Cells
  • Homologous Recombination*
  • Humans
  • RNA / metabolism*
  • Transcription, Genetic / radiation effects

Substances

  • RNA
  • DDX1 protein, human
  • DEAD-box RNA Helicases

Grants and funding

The Alberta Cancer Foundation (grant number 25033) and the Canadian Breast Cancer Foundation provided funding to Roseline Godbout. The Alberta Innovates Health Solutions provided stipend funding to Devon R. Germain.